Letrozole, 100mg (1mg/100tabs)
$97.15 If paid in BTC $77.72
Letrozole, 100mg 1mg
Total amount of active ingredient: 100mg
Quantity: 100 tabs
Shelf Life: 36 months
Packaging: Capsulated and in Mylar Bags
Label: 7.5cm x 2.8cm
•USA: $6.95 (3-7 business days)
•CA: $10.50 (3-7 business days)
•International: $39 (7-14 business days)
If your shipment was seized (International Orders), we will provide a 50% discount applicable on your next purchase. Please contact us for more information.
Products are made and housed in the USA and Europe.
Letrozole is an aromatase inhibitor which is utilized in the treatment of hormonally-responsive bosom malignant growth after a medical procedure. It is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor-positive or has an unknown receptor status in postmenopausal women.
Comparison with tamoxifen
Tamoxifen is likewise used to treat hormonally-responsive bosom malignant growth, yet it does as such by meddling with the estrogen receptor. However, letrozole is successful just in post-menopausal ladies, in whom estrogen is delivered overwhelmingly in fringe tissues (for example in fat tissue, similar to that of the bosom) and various locales in the cerebrum. In pre-menopausal ladies, the fundamental wellspring of estrogen is from the ovaries, not the fringe tissues, and letrozole is inadequate.
In the BIG 1–98 Study, of post-menopausal ladies with hormonally-responsive bosom malignant growth, letrozole decreased the repeat of disease however didn’t change endurance rate, contrasted with tamoxifen.
Letrozole is contraindicated in ladies having a pre-menopausal hormonal status and during pregnancy and lactation.
Connections Letrozole represses the liver chemical CYP2A6, and to a lesser degree CYP2C19, in vitro, however, no important collaborations with drugs like cimetidine and warfarin have been watched.
All of our products are laboratory tested and the results are periodically published on the website.
Also known as: 4,4′-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile), CGS 20267, Femara